Why Does Gait Matter in Neurology, and How Do You Follow It?

Walking is what your patients most want to keep, and it changes with their disease. Yet it is rarely measured: at most visits it gets one line in the note. This article makes the case for measuring it, then gives a way to follow it from one visit to the next.

Clinician watching an older man walk across a clinic room
AI-generated editorial illustration.

One finding shows how much a walk can carry: could gait change years before a Parkinson's diagnosis? Several studies say it does. More on that below.

Why does gait matter in neurology?

1. It is what patients value most. In a study of 166 people with multiple sclerosis, lower limb function was given the highest priority among 13 bodily functions, in early disease and in long-standing disease alike. Heesen et al., Multiple Sclerosis, 2008.

2. It is common, and it is disabling. A review in The Lancet Neurology describes gait impairments as among the most common and disabling symptoms of Parkinson's disease. Mirelman et al., The Lancet Neurology, 2019. In a population study of 488 adults aged 60 to 97, nearly one in three had impaired gait, and about one in four had a neurological gait disorder. Mahlknecht et al., PLoS One, 2013.

3. It says something about what comes next. In that population study, neurological gait disorders were associated with recurrent falls, lower cognitive function, depressed mood and a poorer quality of life. In 597 adults aged 70 and over, gait speed, double support and step-to-step variability each predicted falls over the following 20 months. Verghese et al., Journals of Gerontology Series A, 2009.

4. And it is rarely measured. The same Lancet Neurology review notes that gait is not routinely assessed quantitatively. It is described in general terms, which are not sensitive to the changes that come with disease progression.

That is the gap. The function patients value most, and the one that moves with the disease, is recorded as "gait slow, shuffling".

What does a measurement add to a description?

  • It can show a small change. "Slower than last time" is an impression. A loss of 0.1 m/s is a finding.
  • It gives treatment a before and an after. A change of medication, a block of therapy or a new walking aid can each be set against the same walk.
  • It gives the patient and the family something to see. A line that moves is easier to discuss than a description.
  • It survives a change of clinician. A number recorded with its conditions means the same thing to the next reader.

Why is one walk in the clinic not enough?

A walk down the corridor is a snapshot. It shows the patient on that day, at that hour, with you watching.

Supervised walking and everyday walking are not the same thing. A review in The Lancet Neurology compared mobility assessed under supervision, in the laboratory or the hospital, with mobility assessed unsupervised in daily life. Studies that compared the two directly pointed to large differences, even for the same measures. Warmerdam et al., The Lancet Neurology, 2020.

That does not make the clinic walk worthless. It tells you what the clinic walk is: the patient's performance under known, repeatable conditions. Its value comes from repeating those conditions, visit after visit.

Which conditions should stay the same?

ConditionWhy it matters
Time of day and medication timingIn Parkinson's disease, walking can differ between "on" and "off" states. Record which one you assessed.
Walking aid and footwearA cane, a frame or a different shoe changes the walk you record.
The task and the instruction"Walk at your usual speed" and "walk as fast as you safely can" are different tests.
The pathThe same distance, the same turns, the same floor.
A second taskWalking while talking or counting is a different condition. Use it on purpose or not at all.
FatigueIn multiple sclerosis especially, a walk at the start of the visit and one at the end are not the same walk.

Write the conditions into the note. The next reader, who may be you in six months, needs them to interpret the comparison.

Which measures are worth following?

A few, chosen for the condition and the question.

  • Gait speed. A simple summary of how the patient is walking.
  • Step and stride length. Shorter steps are a familiar feature of parkinsonian gait.
  • Cadence. How the patient produces their speed.
  • Step-to-step variability. How much one step differs from the next.
  • Double support. How long both feet are on the ground together.
  • Left/right symmetry. Useful after stroke, and wherever one side is more affected.

Steadiness review: bring gait variability, double support and symmetry into your review of unsteadiness. These measures describe how the patient walked in the session.

How should you read a change?

  • Check the conditions first. A different medication state or a new walking aid can explain a difference on its own.
  • Look for direction over several visits. One difference between two sessions is a question. The same drift across three or four is a pattern worth acting on.
  • Set it beside the examination. Rating scales, the history and what the family reports all carry information the walk does not.
  • Let treatment changes mark the record. When you change medication or start therapy, note it. The sessions either side become a before and an after.

A measured change is a prompt for clinical reasoning. It is not a diagnosis, and it does not stage a disease.

The open question: does gait change before a Parkinson's diagnosis?

Several studies say it does, by years.

  • In healthy adults followed forward. Researchers assessed the walking of 696 healthy adults, with an average age of 63, every two years with a wearable sensor on the lower back. Sixteen were later diagnosed with Parkinson's disease, on average 4.5 years after the first visit. In them, higher step time variability and greater asymmetry at that first visit were associated with a shorter time to diagnosis. The authors' modeling suggested that walking began to deviate about four years before the diagnosis. Del Din et al., Annals of Neurology, 2019.
  • In people at high risk, examined every year. Among 78 patients with REM sleep behavior disorder, a sleep condition that carries a very high risk of parkinsonism, 20 went on to develop it. Gait abnormalities appeared an estimated 4.4 years before the diagnosis. The Timed Up and Go moved away from normal values an estimated 6.3 years before. Postuma et al., Brain, 2012.
  • In a population followed for 23 years. A study compared 109 people who developed Parkinson's disease with matched controls. Signs of slowness of movement were more frequent from seven years before the diagnosis, and postural imbalance appeared in the last five. Darweesh et al., Brain, 2017.
  • In step-to-step variability, again. In 42 people with probable REM sleep behavior disorder, stride time varied 29% more than in 492 controls of the same age, before any overt parkinsonism. McDade et al., Movement Disorders, 2013.

Four teams, four designs, one direction: movement, and walking in particular, changes years before the diagnosis is made.

What research is working on now: combining gait with other early markers. The authors of the first study expect quantitative gait measures to play an important role in recognizing this early phase. Today these are findings in groups, and the diagnosis remains clinical.

What it shows is where to look: step-to-step variability and asymmetry, which a repeated measurement can follow over years.

How do you make it routine?

  • Fix the moment. The same point in every visit, before the examination tires the patient.
  • Fix the protocol. One task, one path, one instruction, printed on a card.
  • Fix the measures. The same short list for each condition you follow.
  • Review with the patient. Show them the comparison. It is their record.

Timed clinical tests fit the same routine. See the Timed Up and Go test and Parkinson's disease and walking.

Where does Baliston Health fit?

A baseline, then the same walk at each visit. Sensor insoles equipped with AI Mov-Scan capture the patient's walk in suitable shoes. AI Mov-Scan captures. The platform analyzes and generates the Full Clinical Report. Balia, the platform's AI assistant, explains. The practitioner decides.

You review gait speed, stride length, cadence, variability, double support and symmetry: the measures listed above. You set them beside the neurological examination and the history, and you compare sessions over time for the same patient. The analyses available depend on the product and its configuration.

Explore Baliston Health for neurology and geriatrics, read how walking changes with age, or book a demo.

FAQ

Is the walk I see in clinic the patient's usual walk?
Not necessarily. It is their walk under supervised, known conditions. That is why keeping those conditions the same matters.
Should I assess patients with Parkinson's disease "on" or "off" medication?
Choose according to your clinical question, record which state you assessed, and keep it the same at each visit.
Can gait measures predict a fall?
In research, yes: gait speed, double support and step-to-step variability each predicted falls in a study of 597 older adults. Those are findings in groups. For your patient, bring them into your review of steadiness, alongside the examination and the history.
Can gait analysis detect Parkinson's disease early?
Several studies show that walking changes years before the diagnosis, by about four years in two of them. Researchers are now combining gait with other early markers. Today these are findings in groups, and the diagnosis remains clinical.
The movement behind this article
See what your movement is saying.

In three minutes, your practitioner has the Full Clinical Report. Each assessment provides 30+ biomechanical parameters tailored to the selected analysis to support their interpretation. Ask your practitioner about a Baliston movement assessment.

How Baliston works → For practitioners — book a demo →